Rocket Lab shares tumble on Neutron rocket delay to late 2026
Stage 1 tank failure during testing pushes back maiden launch of key growth vehicle despite strong quarterly results
Rocket Lab USA shares slumped approximately 5% in pre-market trading on Friday after the aerospace company delayed the inaugural launch of its Neutron rocket to the fourth quarter of 2026, citing a Stage 1 tank failure during qualification testing. The stock fell to $69.05, extending losses from after-hours trading, as investors focused on the setback overshadowing otherwise strong quarterly results.
The company disclosed that a Neutron Stage 1 tank ruptured during hydrostatic pressure testing in January, revealing a manufacturing defect that requires corrective action before the vehicle can proceed to its maiden flight. The new timeline pushes the Neutron's debut back from previous internal targets, raising concerns about execution risk for what represents Rocket Lab's primary long-term growth catalyst.
"The Neutron timeline update dictating stock direction more than quarterly results," analysts noted, reflecting investor skepticism about the company's ability to execute on its most ambitious development program. The delay marks a significant setback for Rocket Lab's strategy to compete directly with SpaceX's Falcon 9 in the medium-lift launch market.
Despite the Neutron setback, Rocket Lab reported record quarterly revenue of $180 million for Q4 2025, representing a 38% increase year-over-year for full-year 2025, which reached $602 million. The company also achieved a record total backlog of $1.85 billion at the end of the quarter, surging 73% compared to the prior year.
The strong operational performance from the company's Electron small launch vehicle and space systems business provided little comfort to investors focused on the Neutron delay. Analysts pointed out that while the existing business generates steady revenue, the company's valuation at approximately $37.4 billion reflects significant premium expectations for the Neutron program's success.
During the earnings call on February 26, management also forecast higher-than-expected core losses for the first quarter of 2026, adding to investor concerns. The combination of delayed Neutron timeline and increased near-term losses triggered an after-hours slump that continued into pre-market trading.
The stock's decline follows a remarkable run for Rocket Lab, which has seen its shares more than quadruple from their 52-week low of $14.71, touching a high of $99.58 earlier this year. The company's rapid ascent has been fueled by enthusiasm for its vertically integrated approach to space services, combining launch capabilities with satellite manufacturing through its Photon platform.
Despite the pullback, the analyst consensus remains bullish on Rocket Lab with a "Buy" rating. Of 15 analysts covering the stock, two rate it as a Strong Buy, eight as Buy, and five as Hold, with none recommending Sell. The average price target stands at $83.96, implying significant upside from current levels even after the recent decline.
The Neutron rocket represents Rocket Lab's transition from small satellite launches to competing in the medium-lift market, where larger payloads and national security contracts offer substantially higher revenue potential. The vehicle is designed to be partially reusable, featuring a first stage capable of returning to Earth for recovery, similar to SpaceX's Falcon 9 architecture.
The tank rupture incident highlights the technical challenges inherent in developing new launch vehicles, even for a company with Rocket Lab's track record. The company has successfully launched more than 50 Electron rockets since entering service in 2018, establishing itself as a reliable provider in the small satellite market.
Investors will now focus on Rocket Lab's ability to address the manufacturing defect, complete additional testing, and maintain credibility on the new Q4 2026 launch target. The company's next update on Neutron development progress will likely come in conjunction with its first-quarter earnings report, where management will need to demonstrate concrete progress to restore investor confidence.
The delay also provides competitors with additional time to solidify their positions in the medium-lift market, which includes not only SpaceX but also emerging players like Relativity Space and United Launch Alliance's Vulcan rocket. Every quarter of delay increases the competitive pressure on Neutron's eventual commercial debut.